Hangyuan Guo
- Infectious Diseases top 1%
- Neurology top 2%
- Cardiology and Cardiovascular Medicine top 5%
- Oncology top 10%
- Molecular Biology
- Topics
- Protease and Inhibitor Mechanisms (7 papers)Lipoproteins and Cardiovascular Health (4 papers)Atherosclerosis and Cardiovascular Diseases (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Hangyuan Guo
33 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Infectious Diseases 974
- Neurology 522
- Cardiology and Cardiovascular Medicine 443
- Oncology 381
- Molecular Biology 278
Countries citing papers authored by Hangyuan Guo
This map shows the geographic impact of Hangyuan Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangyuan Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangyuan Guo more than expected).
Fields of papers citing papers by Hangyuan Guo
This network shows the impact of papers produced by Hangyuan Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangyuan Guo. The network helps show where Hangyuan Guo may publish in the future.
Co-authorship network of co-authors of Hangyuan Guo
This figure shows the co-authorship network connecting the top 25 collaborators of Hangyuan Guo. A scholar is included among the top collaborators of Hangyuan Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hangyuan Guo. Hangyuan Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 2 | |
| 3 | 22 | |
| 4 | Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysisbreakdown → | 1410 |
| 5 | 124 | |
| 6 | 12 | |
| 7 | 16 | |
| 8 | 15 | |
| 9 | 25 | |
| 10 | 1 | |
| 11 | 11 | |
| 12 | 4 | |
| 13 | 6 | |
| 14 | 5 | |
| 15 | 12 | |
| 16 | 28 | |
| 17 | 8 | |
| 18 | 10 | |
| 19 | 3 | |
| 20 | 6 |
About Hangyuan Guo
Hangyuan Guo is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine and Rheumatology, having authored 33 papers that have together received 2.2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (7 papers), Lipoproteins and Cardiovascular Health (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). The work is most often cited by research in Infectious Diseases (974 citations), Neurology (522 citations) and Modeling and Simulation (118 citations). Hangyuan Guo has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Fang Peng, Weiliang Tang, Yangbo Xing, Shuqing Liu, Huahua Liu, Yan Zhou, Jingjing Zhao, Qingsong Li, Buyun Xu and Jiahao Peng. Their work appears in journals such as Journal of the American College of Cardiology, Scientific Reports and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.